The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration

Journal of Neural Transmission

Volumn 104, Issue 1, 1997, Pages 97-104

  Gao, X M ^a   Hashimoto, T ^a   Cooper, T B ^b   Tamminga, C A ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Chronic clozapine; Chronic haloperidol; Dose response; Oral dyskinesias; Tardive dyskinesia

Indexed keywords

CLOZAPINE; HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DYSKINESIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TARDIVE DYSKINESIA;

ADMINISTRATION, ORAL; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; HALOPERIDOL; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031026006     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271298     Document Type: Article

References (29)

1. Bianchetti G, Morselli PL (1978) Rapid and sensitive method for determination of haloperidol in human samples using nitrogen-phosphorous selection detection. J Chromatogr 153:203-210
2. Clow JM (1980) Changes in cerebral dopamine treatment, long term effects of neuroleptics. Adv Biochem Psychopharmacol 24: 134-139
3. Centorrino F, Baldessarini RJ, Kando J, Frankenburg FR, Volpicelli SA, Puopolo PR, Flood JG (1994) Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry 151: 123-125
4. Dave M (1994) Clozapine-related tardive dyskinesia: case report. Biol Psychiatry 35: 886-887
5. Gao XM, Kakigi T, Friedman MB, Tamminga CA (1994) Tigabine inhibits haloperidol-induced oral dyskinesias in rats. J Neural Transm [Gen Sect] 95: 63-69
6. 2 dopamine antagonists. Collegium International Neuro-Psychopharmacologicum Congress, Washington, DC, June 28, 1994
7. Gunne LM, Growdon J, Glaeser B (1982) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77: 134-139
8. Gunne LM, Haggstrom JE, Sjoqust B (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309: 347-349
9. Gunne LM, Andersson U, Bondesson U, Johansson P (1986) Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol Biochem Behav 25: 897-901
10. Hashimoto T, Gao XM, Shirakawa O, Kakigi T, Tobin AJ, Tamminga CA (1994) Effect of chronic neuroleptic administration on rat oral dyskinesia and the mRNA expression of GAD enkephalin and substance p. Neurosci Abstr 20: 667.10
11. Hyttel J (1991 ) Sertindole: a new concept in neuroleptic research. Biol Psychiatry 29: 553-555
12. Iversen SD, Howells RB, Hughes RF (1980) Behavioral consequences of long-term treatment with neuroleptic drugs. Adv Biochem Psychopharmacol 24: 305-313
13. Kakigi T, Gao X-M, Tamminga CA (1995) Drug-induced oral dyskinesias in rats after traditional and new neuroleptics. J Neural Transm [Gen Sect] 101: 41-49
14. Kane JM, Woerner M, Liebermann J (1985) Tardive dyskinesia: prevalence incidence. and risk factors. In: Casey DE, Chase TN, Chrislensen AV, Gerlach J (eds) Dyskinesia research and treatment. Springer, Berlin Heidelberg New York Tokyo, pp 72-78
15. Kane JM, Woerner MG, Pollack S (1993) Does clozapine cause tardive dyskinesia? J Clin Psychiatry 54: 327-330
16. Kaneda H, Shirakawa O, Dale J, Goodman L, Bachus SE, Tamminga CA (1992) Coadministration of progabide inhibits haloperidol-induced oral dysknesias in rats. Eur J Pharmacol 212: 43-49
17. Kohler C, Hall H, Magnusson O (1990) Biochemical pharmacology of the atypical neuroleptic remoxipride. Acta Psychiatr Scand [Suppl] 358: 27-36
18. 2-dopaminergic receptors in the primate cerebral cortex. Proc Natl Acad Sci USA 91: 4353-4356
19. McKinney WT Jr, Bunney WE Jr (1969) Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry 21: 240-248
20. Mithani S, Atmadja S, Baimbridge KG, Fibinger HC (1987) Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Psychopharmacology 93: 94-100
21. Rupniak NMJ, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD (1984) Differential effects of continuous adminstration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Psychopharmacology 4: 503-511
22. A and dopamine D binding site correlates of haloperidol-induced oral dyskinesia as in rats. Exp Neurol 127: 62-69
23. Simpson GM, Cooper TB (1978) Clozapine plasma levels and convulsions. Am J Psychiatry 135: 99-100
24. Skarsfeldt T, Perregaard J (1990) Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat. Eur J Pharmacol 182: 613-614
25. Tamminga CA, Dale JM, Goodman E, Kaneda H, Kaneda N (1990) Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology 102: 474-478
26. Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao X-M (1994) Clozapine in tardive dyskinesia: observations from human and animal model studies. J Psych Res 55: 102-106
27. Tarazi FI, Florijn WI, Creese I (1994) Regulation of dopamine receptor binding following chronic neuroleptic treatment. Center for Molecular and Behavioral Neuroscience. Rutgers University, Newark NJ. Neurosci Abstr 726.2
28. Waddington JE (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101: 431-447
29. Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1982) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220: 530-532